Home

JAMES E THOMAS

CIK 1204789 · last filed 2022-04-25

JAMES E THOMAS is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $85.5M of CRXTW on Apr 25, 2022. Across all open-market trades the lifetime net is −$82.0M, making them a net seller over the disclosed history. 12 SEC filings were submitted jointly with THOMAS MCNERNEY & PARTNERS LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

14

Lifetime Open-Market Net

-$81.98M

Filer Profile

Reported Address
WOODS END ROAD
NEW CANAAN, CT 06840
Related Filers
THOMAS MCNERNEY & PARTNERS LP — 12 joint filings, latest 2022-04-25
TMP Associates II LP — 9 joint filings, latest 2022-04-25
TMP Nominee II, LLC — 9 joint filings, latest 2022-04-25
Thomas, McNerney & Partners II L.P. — 9 joint filings, latest 2022-04-25
Thomas, McNerney & Partners II, LLC — 9 joint filings, latest 2022-04-25
Alex Zisson — 3 joint filings, latest 2013-07-17
ERIC AGUIAR — 1 joint filings, latest 2013-07-17
Pratik Shah — 1 joint filings, latest 2013-07-17
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted 10%+ Owner 542 $0.01 $7 -$85.45M 1 2022-04-25
CAS MEDICAL SYSTEMS INC (CASM) Delisted Director 8,025 — — $2.09M 11 2019-04-22
Coley Pharmaceutical Group, Inc. (COLY) Delisted Director 2,038,632 — — $1.39M 1 2007-05-14

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-04-25 Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Sell (S) −33,776,208 -$85.45M EDGAR
2019-04-22 CAS MEDICAL SYSTEMS INC (CASM) Delisted Disp (D) −63,454 -$155.5K EDGAR
2018-12-17 CAS MEDICAL SYSTEMS INC (CASM) Delisted Grant (A) +15,000 $0 EDGAR
2017-12-26 CAS MEDICAL SYSTEMS INC (CASM) Delisted Grant (A) +15,000 $0 EDGAR
2017-01-11 CAS MEDICAL SYSTEMS INC (CASM) Delisted Grant (A) +12,500 $0 EDGAR
2015-12-21 CAS MEDICAL SYSTEMS INC (CASM) Delisted Grant (A) — $0 EDGAR
2015-03-31 CAS MEDICAL SYSTEMS INC (CASM) Delisted Grant (A) — $0 EDGAR
2015-02-13 CAS MEDICAL SYSTEMS INC (CASM) Delisted Buy (P) +1,605,000 $2.09M EDGAR
2015-01-07 CAS MEDICAL SYSTEMS INC (CASM) Delisted Grant (A) — $0 EDGAR
2013-07-17 — Mixed +21,947,121 $131.68M
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.